Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Grégory Behar
CEO | Chief Executive Officer | 55 | 01/01 |
Director of Finance/CFO | - | 03/04/23 | |
Ulrike Lemke
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Luc Burgard
COO | Chief Operating Officer | 43 | - |
Marc Funk
BRD | Director/Board Member | 64 | 01/01/21 |
Human Resources Officer | - | - | |
Kieran Chouhan
PRN | Corporate Officer/Principal | - | 01/02/19 |
Bernard Pluta
PRN | Corporate Officer/Principal | - | 01/10/15 |
Shabbir Mostafa
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 60 | 01/06/15 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Steven Klosk
BRD | Director/Board Member | 67 | 01/03/21 |
Director/Board Member | 67 | 01/01/21 | |
Richard Ridinger
CHM | Chairman | 66 | 01/03/21 |
Marc Funk
BRD | Director/Board Member | 64 | 01/01/21 |
Director/Board Member | 43 | 01/03/21 | |
Henrik Giver
BRD | Director/Board Member | 35 | 01/01/21 |
Director/Board Member | - | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 370 000 | 0 | 0 | 56,25 % |
Azione B | 10 | 21 312 000 | 0 | 0 | |
Azione C | 1 | 79 803 683 | 57 089 305 ( 71,54 %) | 0 |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Recipharm Ltd.
Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom. |
Pharmaceuticals: Major
|
Recipharm Holdings Ltd.
Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom. |
Miscellaneous
|
Recipharm Venture Fund AB
Recipharm Venture Fund AB Investment ManagersFinance Recipharm Venture Fund AB is a venture capital fund that makes strategic investments in start-ups and biotechnology companies that are seen as important to Recipharm's business. The fund invests in both private and public companies. |
Investment Managers
|
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+5,48% | 71,19 Mrd | |
+12,55% | 9,3 Mrd | |
-13,75% | 5,01 Mrd | |
+42,38% | 4,47 Mrd | |
+4,51% | 3,96 Mrd | |
+21,10% | 2,44 Mrd | |
-19,05% | 2,41 Mrd | |
-28,72% | 2,23 Mrd | |
+11,13% | 2,02 Mrd |